SCHEMBL19080057

SCHEMBL19080057

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6cc7c(cc6c5)oc5c6ccccc6c6ccccc6c75)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.36
MCL1 Q07820 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
ARSA P15289 1/20 0.34
CDC25A P30304 1/20 0.34
CDC25C P30307 1/20 0.34
PRKDC P78527 1/20 0.34
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
PSD A5PKW4 1/20 0.33
PIM1 P11309 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 1/20 0.32
ATM Q13315 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080074 0.93 ALOX5 (0.34) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL19080053 0.93 ALOX5 (0.36) ALOX5MCL1ACMSDARSACDC25A
SCHEMBL19079965 0.92 ALOX5 (0.33) ALOX5PRKDCCYP1A1CYP1B1PSD
SCHEMBL19080091 0.92 GPR84 (0.35) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL19080028 0.89 ESR1 (0.36) ALOX5MCL1ARSACDC25ACDC25C
SCHEMBL19080071 0.89 SOS1 (0.34) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL19080051 0.88 CYP1A1 (0.42) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL17945177 0.88 ALOX5 (0.39) ALOX5MCL1ACMSDARSACDC25A
SCHEMBL17943909 0.88 ALOX5 (0.42) ALOX5MCL1ACMSDARSACDC25A
SCHEMBL19080085 0.87 CYP1A1 (0.35) ALOX5ARSACDC25ACDC25CPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALOX5 1871/4885MCL1 1092/4885ACMSD 1768/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALOX5 1871/4885MCL1 1092/4885ACMSD 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.